跳至主要内容
临床试验/JPRN-UMIN000047501
JPRN-UMIN000047501已完成未知

A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma - A retrospective study to explore the efficacy and safety of FOLFOX therapy and FOLFOX with radiation in esophageal squamous cell carcinoma

ational Hospital Organization Nagoya Medical Center, Department of Medical Oncology0 个研究点目标入组 143 人开始时间: 2022年4月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
143

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Duplicate cancers (simultaneous duplicate cancers and iatrogenic duplicate cancers with a disease-free interval of 3 years or less). However, patients with overlapping cancers that are not prognostic factors are not excluded. Patients with cardiovascular complications that are not stabilized by pharmacological therapy alone.

研究者

发起方
ational Hospital Organization Nagoya Medical Center, Department of Medical Oncology

相似试验

招募中
Unknown
A retrospective study to evaluate the efficacy and safety of carbon ion radiation therapy for primary lung cancer.primary lung cancer
JPRN-UMIN000052389ational institutes for Quatum Science and Technology150
已完成
不适用
A prospective study investigating the efficacy and safety of traction-band-assisted endoscopic closure for mucosal defect after colorectal endoscopic submucosal dissection: A multi-center trial (TBEC Trial)Colorectal neoplasms
JPRN-UMIN000047953Kitakyushu Municipal Medical Center34
尚未招募
2 期
Chemoradiation and immunotherapy for unresectable skin squamous cell carcinomaskin cancersquamous cell carcinoma
ACTRN12618001573246Metro North Hospital and Health Service15
进行中(未招募)
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.Chronic spontaneous urticaria and the following skin disorders:1 - Eczema/dermatitis (acute eczema, chronic eczema, contact dermatitis, atopic dermatitis, nummular eczema, autosensitisation dermatitis, dyshidrotic eczema, asteatotic eczema, lichen simplex chronicus).2 - Prurigo (acute prurigo, subacute prurigo, chronic prurigo).3 - Cutaneous pruritus (systemic cutaneous pruritus, local cutaneous pruritus).MedDRA version: 19.0Level: HLTClassification code 10012435Term: Dermatitis and eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10037083Term: PrurigoSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10052568Term: Urticaria chronicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disorders
EUCTR2016-001505-17-ESFAES FARMA, S.A.115
进行中(未招募)
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.
EUCTR2016-001505-17-HUFAES FARMA, S.A.115